December 17, 2019
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) released the following statement following the organization’s testimony before the Senate Judiciary Committee on “Tackling the Opioid Crisis: A Whole-of-Government Approach.”
“We appreciate the committee’s continued interest and focus on policy solutions to address prescription opioid abuse and misuse.
“Distributors are committed to enhancing the safety and security of the prescription supply chain, while ensuring medicines are appropriately made available to the patients who need them.
“Through collaboration with our supply chain partners and state and federal agencies, including the Drug Enforcement Administration (DEA), HDA’s distributor members have invested heavily in information technology systems and state-of-the-art monitoring tools to prevent diversion and improve the monitoring of controlled substances. Additionally, HDA advocated for the SUPPORT (Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities) Act and is working to implement new provisions as part of this law to enhance information sharing and collaboration between our distributor members and the DEA.
“HDA supports comprehensive solutions to enhance and improve the pharmaceutical supply chain’s collective response to the misuse and abuse of prescription opioids. This includes HDA’s role as the founding member of Allied Against Opioid Abuse, a national education and awareness coalition working to address the prescription opioid abuse crisis in a meaningful way by educating patients about the rights, risks and responsibilities associated with opioid medicines.
“We stand ready to continue working with our supply chain partners, government agencies and other stakeholders who are committed to solving this national public health crisis.”
HDA's testimony may be viewed here.
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.